Fibronectin as an Early Predictor of Gestational Hypertension/Preeclampsia.

Simple item page
dc.contributor.authorDG, Geetaen_US
dc.contributor.authorIqbal, Yasminen_US
dc.date.accessioned2020-11-18T10:18:03Z
dc.date.available2020-11-18T10:18:03Z
dc.date.issued2020-02
dc.description.abstractHypertensive disorders complicate 2% to 8% of pregnancies globally. They are one of the leading causes of maternal mortality responsible for 16% of maternal deaths. Preeclampsia is a pregnancy specific syndrome whose pathophysiologic features have not been clearly established, but research during past two decades has suggested that maternal endothelial damage and improper placental development are involved in the genesis of preeclampsia. Fibronectin is known to be a marker of endothelial dysfunction, which occurs in early gestation in women who develop preeclampsia in later gestation and hence levels of fibronectin may vary in first trimester itself in such women. We wanted to examine the usefulness of single biomarker ‘plasma fibronectin’ in screening of pregnant women for gestational hypertension/preeclampsia, study the difference in fibronectin levels in early versus late onset gestational hypertension/preeclampsia and evaluate its levels in preeclampsia with severe features.METHODS200 antenatal women with singleton pregnancy, who were normotensive were enrolled in the study and plasma fibronectin levels were measured at 10-12 weeks of gestation. Women were followed throughout pregnancy and 12 weeks postpartum. Plasma fibronectin levels were compared between normotensive women and women who developed gestational hypertension/preeclampsia.RESULTSThe mean values of plasma fibronectin are significantly higher in group who developed gestational hypertension/preeclampsia compared to group who remained normotensive (167+/-81 vs 114+/-58; p<0.05). The mean value in group with early onset disease as well as preeclampsia with severe features is higher than that of group with late onset disease and preeclampsia without severe features respectively. But the difference is not statistically significant.CONCLUSIONSStudy showed that plasma fibronectin could be used as a marker for early prediction of gestational hypertension/ preeclampsia.en_US
dc.identifier.affiliationsDepartment of Obstetrics and Gynaecology, Bhabha Atomic Research Centre Hospital, Mumbai, Maharashtra, India.en_US
dc.identifier.affiliationsDepartment of Obstetrics and Gynaecology, Muslim Maternity and Children s Hospital, Hyderabad, Telangana, Indiaen_US
dc.identifier.citationDG Geeta, Iqbal Yasmin. Fibronectin as an Early Predictor of Gestational Hypertension/Preeclampsia.. Journal of Evolution of Medical and Dental Sciences. 2020 Feb; 9(8): 512-515en_US
dc.identifier.issn2278-4802
dc.identifier.issn2278-4748
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/214670
dc.languageenen_US
dc.publisherAkshantala Enterprises Private Limiteden_US
dc.relation.issuenumber8en_US
dc.relation.volume9en_US
dc.source.urihttps://dx.doi.org//10.14260/jemds/2020/115en_US
dc.subjectHDPen_US
dc.subjectGestational Hypertensionen_US
dc.subjectPreeclampsiaen_US
dc.subjectFibronectinen_US
dc.subjectEndothelial Dysfunctionen_US
dc.subjectPredictoren_US
dc.titleFibronectin as an Early Predictor of Gestational Hypertension/Preeclampsia.en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jemds2020v9n8p512.pdf
Size:
593.54 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Evolution of Medical and Dental Sciences